The EU-funded BRAINTEASER project aims to bring Artificial Intelligence home for a better care of amyotrophic lateral sclerosis and multiple sclerosis.

PRIME is an EU-funded project (H2020-EU.3.1.1. - Understanding health, wellbeing and disease) and states that insulin signalling not only affects the body (e.g., diabetes and obesity) but also the brain (e.g., Alzheimer’s disease, autism and obsessive-compulsive disorders).

AGORA is an ERA-NET NEURON-funded project aiming to improve the effectiveness of therapy of chronic neuropathic pain (CNP) and rate of responders in future clinical trials delivering the treatment to targeted subgroups of patients.

Full project name: EU4Health Integration and Impact Initiative Duration: 12 months Consortium: I3h Institute (I3h ULB), One Sustainable Health for All Foundation (OSH Foundation), Childhood Cancer International Europe (CCI Europe), European Brain Council (EBC) Description: The EU4Health Integration and Impact Initiative (EU4H3I) aims to address public health challenges such as healthcare disparities, unequal access [...]

Coordinated by EBC, EBRA enhances coordination and collaboration among members that share the common goal of understanding the brain and its disorders by synergising brain related projects and initiatives at both European and global level ...

The EU-funded MULTI-ACT project aims to increase the impact of health research on people with brain diseases. It will create and implement a new model allowing for the effective cooperation of all relevant stakeholders.

The EU-funded AD Detect-Prevent project, which is led by the Danish company Brain+, kicked-off in late 2018 and will continue over the next two years with the aim of developing a digital tool to improve early detection of Alzheimer’s disease.

ASCTN-Training is a four-year project, funded by the European Union Horizon 2020 Programme (H2020-MSCA-ITN-2018) under the Marie Skłodowska-Curie Initial Training Network and Grant Agreement No. 813851.

AETIONOMY is a consortium brought together under the European IMI to tackle the problem of the classification of neuro-degenerative diseases. Revising the taxonomy (classification) will take many years to complete and to be accepted by the biomedical community.

ADVANCE-HTA is a research project funded by the European Commission's Research Framework Programme (FP7). It comprises several complementary streams of research that aim to advance and strengthen the methodological tools and practices relating to the application and implementation of Health Technology Assessment (HTA).